• SENSEX
    NIFTY 50
Healthcare

Cipla to acquire 11.71% stake in Wellthy Therapeutics

Updated : February 18, 2019 11:51 PM IST

Goldencross Pharma, a wholly-owned subsidiary of Cipla, has inked an agreement to acquire the minority stake in the Mumbai-based firm for a cash consideration of Rs 10.5 crore, Cipla said in a regulatory filing.
As part of the deal, the partners plan to offer a combination of pharmacotherapy and digital therapeutics for improved patient outcomes in the chronic therapies of diabetology and cardiology, it added.
Cipla to acquire 11.71% stake in Wellthy Therapeutics

You May Also Like

Live TV
Advertisement